Regulation of the type II oncostatin M receptor expression in lung-derived epithelial cells

J Cichy1, S Rose-John, E Puré

  • 1Department of Microbiology and Immunology, Institute of Molecular Biology, Jagiellonian University, Cracow, Poland. JCichy@wista.wistar.upenn.edu

FEBS Letters
|July 14, 1998
PubMed

Insights

Oncostatin M (OSM) signaling in lung epithelial cells involves specific receptors. This study investigates the OSM-specific receptor

Area of Science:

  • Cellular and Molecular Biology
  • Cytokine Signaling Pathways
  • Respiratory Medicine

Background:

  • Oncostatin M (OSM) is a cytokine that modulates human lung-derived epithelial cell function.
  • OSM utilizes two receptor complexes: a type I receptor shared with leukemia inhibitory factor (LIF), and a type II OSM-specific receptor.
  • The distinct roles of these receptors in mediating cellular responses to OSM are not fully understood.

Purpose of the Study:

  • To investigate the role of the OSM-specific receptor in mediating lung epithelial cell responses to OSM.
  • To characterize the expression of type II OSM receptor mRNAs in lung-derived epithelial cells.
  • To determine how cytokines and dexamethasone regulate the expression of mRNAs encoding components of the OSM-specific receptor.

Main Methods:

  • Analysis of gene expression in lung-derived epithelial cells.
  • Characterization of mRNA expression for type II OSM receptor components.
  • Investigating the regulatory effects of cytokines and dexamethasone on receptor gene expression.

Main Results:

  • OSM induces specific protein synthesis (alpha1-antichymotrypsin and alpha1-antiproteinase inhibitor) in lung epithelial cells, distinct from LIF's effects.
  • Evidence suggests that the OSM-specific receptor mediates these differential responses.
  • Characterization of type II OSM receptor mRNA expression and its regulation was performed.

Conclusions:

  • Lung epithelial cells express components of the OSM-specific receptor.
  • The OSM-specific receptor likely mediates the unique responses of lung epithelial cells to Oncostatin M.
  • Further research into the regulation of this receptor by cytokines and dexamethasone is warranted.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...